HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Claims Support, Consumer Dialogue Reduce Lawsuit Risk – Attorneys

This article was originally published in The Rose Sheet

Executive Summary

The cosmetics industry has become a recent target for activist lawyers and class-action suits, but firms can decrease their chances by substantiating claims. Attorneys from Loeb & Loeb discussed the topic during a session at HBA Global Expo in New York.

You may also be interested in...



Plaintiffs Suffer Setback In Suit Disputing “Magnetic” Dial For Men Claims

Plaintiffs strike out with women and a California district court judge as multiple claims are dismissed in a suit alleging false advertising for Dial for Men Magnetic body wash, which evidently does not guarantee attention from the opposite sex.

Aggressive Claims, FDA Warnings Make Beauty A Bull’s Eye For Litigation

Class-action suits against beauty firms on the rise as industry pushes the envelope with claims and FDA warning letters draw attention from class-action law firms, legal experts note. Hogan Lovells attorney Mark Goodman says: “I don’t see this [trend] going away anytime soon.”

Rash Of FDA Warning Letters Raises Questions For Cosmetics Industry

EAS Consulting rep John Bailey, who directed FDA’s cosmetics program in the 1990s and served as PCPC chief scientist through July of 2011, offers his view on the six warning letters issued to cosmetics firms between Sept. 7 and Oct. 5. It’s too early to say whether FDA is taking a more aggressive stance on cosmetics claims, but firms “need to be aware,” Bailey says.

Topics

UsernamePublicRestriction

Register

LL1132972

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel